Anaplastic Multiple Myeloma: An Aggressive Myeloma Variant with A Poor Response to Autologous Stem Cell Transplantation

This publication has 11 references indexed in Scilit:

• Successful outcome of anaplastic multiple myeloma with lenalidomide, cyclophosphamide, and dexamethasone therapy
  Annals of Hematology, 2020
• Clinical and histopathological analyses of anaplastic myeloma
  Chinese Medical Journal, 2020
• Plasma Cell Myeloma with an Aggressive Clinical Course and Anaplastic Morphology in a 22-Year-Old Patient: A Case Report and Review of Literature
  American Journal of Case Reports, 2020
• Poor response to daratumumab and carfilzomib in newly diagnosed anaplastic multiple myeloma
  Journal of Clinical and Experimental Hematopathology, 2020
• CD38 negative anaplastic plasma cell myeloma with (14;16) translocation: a diagnostic dilemma for highly aggressive neoplasm: case report
  Journal of Hematopathology, 2019
• Anaplastic multiple myeloma: possible limitations of conventional chemotherapy for long-term remission
  Journal of Clinical and Experimental Hematopathology, 2018
• CD38—Negative Myeloma with Anaplastic Morphology at Presentation: A Case Report
  Indian Journal of Hematology and Blood Transfusion, 2017
• Plasma cell myeloma with anaplastic transformation
  Blood, 2016
• Anaplastic Multiple Myeloma: An Aggressive Variant With a Poor Response to Novel Therapies
  Clinical Lymphoma Myeloma and Leukemia, 2016
• Sustained remission and reversal of end-organ dysfunction in a patient with anaplastic myeloma
  Annals of Hematology, 2013